Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Insider Trades
  • Long Ideas
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

Insiders Buying Zumiez And 3 Other Stocks

By Avi Kapoor
April 9, 7:29 AM
Although U.S. stocks closed little changed on Monday, there were a few notable insider trades.

ANGO

Read More
2 minute read
  • Earnings
  • FDA
  • General
  • Guidance
  • Health Care
  • Movers
  • News

Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars

By Vandana Singh
April 4, 12:53 PM
FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens treatment options. Sales slightly below consensus, but pro forma basis sees growth.

ANGO

Read More
2 minute read
  • Earnings

Earnings Scheduled For April 4, 2024

By Benzinga Insights
April 4, 5:18 AM
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion.

ANGO

Read More
1 minute read
  • Equities
  • General
  • Legal
  • Markets
  • News

AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement

By Nabaparna Bhattacharya
April 2, 8:51 AM
AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company.

ANGO

Read More
3 minute read
  • Asset Sales
  • News

AngioDynamics Announces Sale Of PICC And Midline Product Portfolios To Spectrum Vascular For $45M

By Benzinga Newsdesk
February 15, 5:30 PM
Portfolio optimization enhances strategic focus and follows initiative to restructure manufacturing footprintCompany to discontinue sales of radiofrequency ablation and Syntrax productsAngioDynamics, Inc. (NASDAQ:ANGO),

ANGO

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

AngioDynamics Announces FDA 510(k) Clearance Of Auryon XL Radial Access Catheter To Treat Peripheral Arterial Disease

By Benzinga Newsdesk
January 23, 9:15 AM
225-cm Catheter Length Expands Access Points in Atherectomy Procedures to Help Reduce Access Site Complications and Accelerate Patient RecoveryAngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical

ANGO

Read More
1 minute read
  • Analyst Ratings

Raymond James Maintains Outperform Rating for AngioDynamics: Here’s What You Need To Know

By Benzinga Insights
January 9, 1:00 PM
Raymond James has decided to maintain its Outperform rating of AngioDynamics (NASDAQ:ANGO) and lower its price target from…

ANGO

Read More
2 minute read
  • Analyst Ratings
  • Markets
  • News
  • Price Target
  • Trading Ideas

Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday

By Avi Kapoor
January 8, 8:42 AM
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

ANGO

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor
January 5, 2:13 PM
Shares of Applied Therapeutics, Inc.

AGL

Read More
2 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Why Is Medical Devices-Focused AngioDynamics Stock Trading Lower Today?

By Vandana Singh
January 5, 11:35 AM
AngioDynamics Inc (NASDAQ: ANGO) has reported a second-quarter (Q2) FY24 adjusted EPS loss of $(0.05), compared to the consensus of $(0.07) and EPS income of

ANGO

Posts pagination

1 2 … 7 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service